Page last updated: 2024-11-07

pilocarpine and Rhabdomyosarcoma

pilocarpine has been researched along with Rhabdomyosarcoma in 1 studies

Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.

Rhabdomyosarcoma: A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar (RHABDOMYOSARCOMA, ALVEOLAR), mainly in adolescents and young adults; embryonal (RHABDOMYOSARCOMA, EMBRYONAL), predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1647-9)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Licht, R1
Kampinga, HH1
Coppes, RP1

Other Studies

1 other study available for pilocarpine and Rhabdomyosarcoma

ArticleYear
Salivary gland-sparing prophylactic pilocarpine treatment has no effect on tumor regrowth after irradiation.
    Radiation research, 2002, Volume: 157, Issue:5

    Topics: Animals; Carcinoma, Squamous Cell; Cell Division; Dose-Response Relationship, Radiation; Humans; Mic

2002